*Sunwin Stevia
announces a New Manufacturing Facility of 500 Metric Tons of High–Grade Stevia
Increasing its Total Manufacturing Capacity of High-Grade Stevia to 1,600
Metric Tons per Year
*Sunwin Stevia
International Receives a Major Purchase Order of over $3.2 million for
Enzyme-Treated Stevia Products
*Sunwin Stevia
International to Receive Patent on the Most Advanced Enzyme-Treated Stevia
Products
QUFU, China, June 3,
2015 -- Sunwin Stevia International, Inc. (OTCQB: SUWN, "Sunwin
Stevia"), one of the top global suppliers of high quality stevia extracts
including Rebaudioside A 98 and Rebaudioside A99, announced today that it has
completed construction of a new manufacturing facility that can produce 500
metric tons of high-grade stevia per year.
The new facility has been in operation to produce high-grade stevia
products on a commercial basis for the market.
In 2014 Sunwin
Stevia invested approximately $2 million to start building this new facility in
order to meet substantially increased demand for its high-grade stevia products.
The new manufacturing facility is fully equipped with stainless steel equipment
without any plastic while it has a fully automated system in order to prevent
any potential contamination from operators and plastic. In addition, the new
manufacturing facility uses the most advanced production equipment that is the
first time to be used for stevia production in the industry, such as scraper
with centrifuge and fluidized drying system.
As of now, Sunwin
Stevia has approximately 1,600 metric tons in manufacturing capacity per year to
produce high-grade stevia extract. With
these manufacturing facilities, Sunwin Stevia is able to deliver stevia
products containing Rebaudioside A in a range of 50% to 99% with a format of
powder, granular, or tablet.
Ms. Dongdong Lin,
CEO of Sunwin Stevia stated, "We believe Sunwin Stevia becomes the largest
manufacturer of high-grade stevia in the world.
We expect the total demand for stevia extract will reach a new level in
2016 and beyond. Our state of the art manufacturing
facilities lay a solid foundation to grow our stevia business. Our total
manufacturing capacity will allow us to grow our annual revenues over $60
million. We will actively market our stevia
products in Europe, Asia, South America, and North America to become a dominant
global high-grade stevia supplier for years to come.”
Read
this release in full at http://www.investorideas.com/CO/SUWN/news/2015/06031.asp
Recent
News:
Sunwin
Stevia International Receives a Major Purchase Order of $3.2 million for Enzyme-Treated Stevia
Products
QUFU, China, May
27, 2015 -- Sunwin Stevia International, Inc. (OTCQB: SUWN, "Sunwin
Stevia"), one of the top global providers of high quality stevia extracts
including Rebaudioside A 98 and Rebaudioside 99, announced today that it has
received a major purchase order of 40 metric tons enzyme-treated stevia
products valued over US$3.2 million for the calendar year of 2015 by Wild
Flavors, Inc.
Sunwin
Stevia International to Receive Patent on the Most Advanced Enzyme-Treated
Stevia Products
QUFU, China, May
27, 2015 -- Sunwin Stevia International, Inc. (OTCQB: SUWN, "Sunwin
Stevia"), one of the top global providers of high quality stevia extracts
including Rebaudioside A 98 and Rebaudioside A 99, announced today that it has
submitted a patent application for its enzyme-treated stevia products.
About Sunwin Stevia International, Inc.
Sunwin
Stevia International, Inc. (OTCQB: SUWN) engages in production and distribution
of zero calorie, all natural sweeteners (Sunwin Stevia™ Extracts). As an
industry leader in high quality stevia production, Sunwin Stevia has built an
integrated firm with the farming and production capabilities to meet the needs
of consumers throughout the world. For more info about Sunwin Stevia, please
visit http://www.sunwininternational.com
Safe
Harbor Statement
Sunwin Stevia International, Inc. is hereby
providing cautionary statements identifying important factors that could cause
our actual results to differ materially from those projected in forward-looking
statements (as defined in such act). Any statements that are not historical
facts and that express, or involve discussions as to, expectations, beliefs,
plans, objectives, assumptions or future events or performance (often, but not
always, indicated through the use of words or phrases such as "will likely
result," "are expected to," "will continue," "is
anticipated," "estimated," "intends," "plans,"
"believes" and "projects") may be forward-looking and may
involve estimates and uncertainties which could cause actual results to differ
materially from those expressed in the forward-looking statements. These
statements include, but are not limited to, our ability to return our revenues
to historical levels, our dependence on continued market acceptance of our
products, competition, our ability to control our raw material costs, risks
associated with operating in China, and other risk factors impacting our
company, some of which may be beyond our control. We caution that the factors described herein
could cause actual results to differ materially from those expressed in any
forward-looking statements we make and that investors should not place undue reliance
on any such forward-looking statements. Further, any forward-looking statement
speaks only as of the date on which such statement is made, and we undertake no
obligation to update any forward-looking statement to reflect events or
circumstances after the date on which such statement is made or to reflect the
occurrence of anticipated or unanticipated events or circumstances. New factors
emerge from time to time, and it is not possible for us to predict all of such
factors. Further, we cannot assess the impact of each such factor on our
results of operations or the extent to which any factor, or combination of
factors, may cause actual results to differ materially from those contained in
any forward-looking statements. This press release is qualified in its entirety
by the cautionary statements and risk factor disclosure contained in our
Securities and Exchange Commission filings, including our Annual Report on Form
10-K for the fiscal year ended April 30, 2014.
Contact:
Peisha Shen
Peisha Shen
U.S. Representative
Telephone: (954) 363-7333
Facsimile: (954) 363-7320
Email: ir@sunwininternational.com
For
more info on SUWN on Investorideas please visit: http://www.investorideas.com/CO/SUWN/
Published at
Investorideas.com newswire
Disclaimer/
Disclosure:The Investorideas.com newswire is a third party publisher of news as
well as creates original content as a news source. Original content created by
investor ideas is protected by copyright laws other than syndication rights.
Investorideas is a news source on Google news and global syndication partners.
Our site does not make recommendations for purchases or sale of stocks or
products. Nothing on our sites should be construed as an offer or solicitation
to buy or sell products or securities. All investment involves risk and
possible loss of investment. This site is currently compensated by featured
companies, news submissions and advertising. Contact each company directly for
press release questions. Disclosure is posted on each release if required but
otherwise the news was not compensated for and is published for the sole
interest of our readers. SUWN: June 3, 2015 : Investorideas.com has been
retained for 2 weeks for PR , media and news dissemination : three thousand
seven hundred and fifty. More info http://www.investorideas.com/About/Disclaimer.asp
BC Residents and
Investor Disclaimer: Effective September 15 2008 - all BC investors should
review all OTC and Pink sheet listed companies for adherence in new disclosure
filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
No comments:
Post a Comment